Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial Friederike BraulkeXenia SchulzDetlef Haase Original Article 03 April 2017 Pages: 887 - 894
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia Anna BothJürgen KrauterKatharina Wagner Original Article 22 March 2017 Pages: 895 - 904
Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β Sylvie Dunoyer-GeindreAnne-Sophie Rivier-CordeyEgbert K. O. Kruithof Original Article Open access 25 March 2017 Pages: 905 - 917
Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms DC ChoiD TremblayJ Mascarenhas Review Article 06 January 2017 Pages: 919 - 927
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation Elisabetta MetafuniSabrina GiammarcoPatrizia Chiusolo Original Article 14 March 2017 Pages: 929 - 933
Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis Ivan Sergeevich MoiseevEkaterina Andreevna BurminaBoris Vladimirovich Afanasyev Original Article 25 March 2017 Pages: 935 - 942
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas B. TessoulinP. ThomareSteven Le Gouill Original Article 03 April 2017 Pages: 943 - 950
Impact of cachexia on outcomes in aggressive lymphomas Reem KarmaliTaha AlrifaiJeffrey A. Borgia Original Article 17 April 2017 Pages: 951 - 956
Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies Feifei ChenJiyi HuPeng Liu Review Article 24 December 2016 Pages: 957 - 965
Refractory plasmablastic lymphoma—a review of treatment options beyond standard therapy Dominik PretscherAlexander KalischJosef Birkmann Review Article 23 December 2016 Pages: 967 - 970
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease Xin-xin CaoQi MengJian Li Original Article 09 March 2017 Pages: 971 - 976
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma Muhamed BaljevicShadia ZamanRobert Z. Orlowski Original Article Open access 23 March 2017 Pages: 977 - 985
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey Maximilian MerzLenka KellermannHartmut Goldschmidt Original Article 13 April 2017 Pages: 987 - 993
Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables Marina BaldiniA. MarconG. Graziadei Original Article 20 March 2017 Pages: 995 - 1003
A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease Pacharapan SurapolchaiAmpaiwan ChuansumritChi-Chiu So Original Article 23 March 2017 Pages: 1005 - 1014
Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach E CassinerioIM BaldiniMD Cappellini Original Article 20 March 2017 Pages: 1015 - 1021
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications Julia KraftRaute Sunder-PlassmannIngrid Pabinger Original Article 30 March 2017 Pages: 1023 - 1031
Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis? Fahad A. S. Al-EidanJ. A. Al-GramishM. A. Crowther Original Article 13 March 2017 Pages: 1033 - 1036
Reactive granulomatous dermatitis presenting as subcutaneous nodules and cords in a patient with advanced myelodysplastic syndrome Jason WeedChristine KoJonathan Leventhal Letter to the Editor 20 February 2017 Pages: 1037 - 1039
Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000–2015 Raffaella OrigaFranco AnniRosa Anna Podda Letter to the Editor 09 March 2017 Pages: 1041 - 1042
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major Elisa BiliottiDonatella PalazzoGloria Taliani Letter to the Editor 05 April 2017 Pages: 1043 - 1045
Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose? Hugo J.A. AdamsThomas C. Kwee Letter to the Editor 11 April 2017 Pages: 1047 - 1048
Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib Panagiotis T. DiamantopoulosMina PsichogiouNora-Athina Viniou Letter to the Editor 28 February 2017 Pages: 1049 - 1050
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient Hideaki MizunoJunji KoyaMineo Kurokawa Letter to the Editor 09 March 2017 Pages: 1051 - 1052
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection João Tadeu Damian Souto FilhoLara Vianna de Barros LemosFernanda Cordeiro da Silva Letter to the Editor 19 March 2017 Pages: 1053 - 1056
Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma Katsuyuki NishiSachiko MitaniKazunori Imada Letter to the Editor 14 March 2017 Pages: 1057 - 1058
Bilateral sciatic nerve neurolymphomatosis: PET/CT findings Luis GorospeJosé Ignacio Gallego-RiveraAnabelle Chinea-Rodríguez Letter to the Editor 03 April 2017 Pages: 1059 - 1060
Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis Yutaka ShimazuHiromitsu Nagata Letter to the Editor 04 April 2017 Pages: 1061 - 1063
Efficacy of neutrophil non-muscle myosin heavy chain-IIA immunofluorescence analysis in determining the pathogenicity of MYH9 variants Shinji KunishimaOkuno YusukeSeiji Kojima Letter to the Editor 14 March 2017 Pages: 1065 - 1066
A de novo ankyrin mutation (ANK1 Q109X) causing severe hereditary spherocytosis from preterm neonatal period Sha LiuHua JiangDong-Zhi Li Letter to the Editor 09 March 2017 Pages: 1067 - 1068